1
TEST OF THE WEEK ADVERTISEMENT T 't S "his test - the first in a . series of three - will help you answer the question: 'What is best, in-house production or third-party f manufacturing?' The second test, to appear in the next issue of this publication, will help you H.R. Marti. Ph.D.; Kurt Stalder (Europe); M. Pfenninger. Ph.D.; K.D. Reichlmeier. Ph.D. (U.S.A. and Japan); Siegfried Chemists. The Marti/Pfenninger/Stalder/Reichlmeier Custom Manufacturing Test Series: Test No-1: MAKE OR IUY /9 Your research people have discovered a new active substance. You're planning for the clinical phase» Do you: D a) Have the in-house production capacity for initial quantities, and later, commercial runs? D b) Find it necessary to bring your existing plant and equip- ment in line with your new project plus commit the necessary personnel to it? D c) Choose none of the above and give custom manufac- turing a try? The time has come to commit more funds to your project. Will you: D a) Invest in the facilities and manpower to produce testing and start-up quanti- ties of an as yet unproven product? D b) Change existing facilities to accomodate the new synthesis, with the atten- dant financial risks? D c) Reduce risk by spending only a minimum on plant, equipment, production engineering, manpower and by instead applying those funds to research for new active substances? How to score: Mostly a's: Although financial, plant and manpower capacities are available, and cost and risk seem within reason, is your project's cost effectiveness all it could be? Mostly b's: You are ideally poised to beat the competition to the punch by streamlining and speeding up traditional ways of bringing a product to market. You might try custom manufacturing. Mostly c's: Nothing will stop you or your company now - you are in effect leasing outside produc- tion facilities and know-how and applying what you saved to the search for new active sub- stances. You're working out a testing schedule and marketing plan. Is your project: D a) In a holding pattern, losing its head start for lack of available production engi- neering and production capacities at your plant? D b) On schedule, after you spent money on equipment and personnel? D c) Proceeding at no extra cost and on schedule toward testing or marketing because you wisely investigated the contract manufacturing option? For the second test of this series, watch for the next edition of this publication. CIRCLE 7 ON READER SERVICE CARD Ο C a n i a m K n r OC ΙΟΟΟΓίΓΜ CH-4800 ZOFINGEN SWITZERLAND TEL. 062 501111 TELEFAX 062 513082 TELEX 982 444 sgf ch SIEGFRIED r CHEMIE The answer you may have been waiting for. decide if a contract manufactur- er has the right facilities to make your product for you. The third test, scheduled for the issue after next, deals with the selection - and se- I lection pitfalls - of the most qualified contractor. Don't miss it. Pharmaceutical fine chemicals: MAKE OR BUY?

Pharmaceutical fine chemicals: MAKE OR BUY?

  • Upload
    dinhtu

  • View
    213

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Pharmaceutical fine chemicals: MAKE OR BUY?

TEST OF THE WEEK ADVERTISEMENT

T't S "his test - the first in a . series of three - will help

you answer the question: 'What is best, in-house production or third-party f manufacturing?' The second test, to appear in the next issue of this publication, will help you

H.R. Marti. Ph.D.; Kurt Stalder (Europe); M. Pfenninger. Ph.D.; K.D. Reichlmeier. Ph.D. (U.S.A. and Japan); Siegfried Chemists.

The Marti/Pfenninger/Stalder/Reichlmeier Custom Manufacturing Test Series:

Test No-1: MAKE OR IUY /9

Your research people have discovered a new active substance. You're planning for the clinical phase» Do you:

D a) Have the in-house production capacity for initial quantities, and later, commercial runs?

D b) Find it necessary to bring your existing plant and equip­ment in line with your new project plus commit the necessary personnel to it?

D c) Choose none of the above and give custom manufac­turing a try?

The time has come to commit more funds to your project. Will you:

D a) Invest in the facilities and manpower to produce testing and start-up quanti­ties of an as yet unproven product?

D b) Change existing facilities to accomodate the new synthesis, with the atten­dant financial risks?

D c) Reduce risk by spending only a minimum on plant, equipment, production engineering, manpower and by instead applying those funds to research for new active substances?

How to score: Mostly a's: Although financial, plant and manpower capacities are available, and cost and risk seem within reason, is your project's cost effectiveness all it could be? Mostly b's: You are ideally poised to beat the competition to the punch by streamlining and speeding up traditional

ways of bringing a product to market. You might try custom manufacturing. Mostly c's: Nothing will stop you or your company now - you are in effect leasing outside produc­tion facilities and know-how and applying what you saved to the search for new active sub­stances.

You're working out a testing schedule and marketing plan. Is your project:

D a) In a holding pattern, losing its head start for lack of available production engi­neering and production capacities at your plant?

D b) On schedule, after you spent money on equipment and personnel?

D c) Proceeding at no extra cost and on schedule toward testing or marketing because you wisely investigated the contract manufacturing option?

For the second test of this series, watch for the next edition of this publication.

CIRCLE 7 ON READER SERVICE CARD Ο C a n i a m K n r OC Ι Ο Ο Ο Γ ί Γ Μ

CH-4800 ZOFINGEN SWITZERLAND

TEL. 062 501111 TELEFAX 062 513082 TELEX 982 444 sgf ch

SIEGFRIED r CHEMIE

The answer you may have been waiting for.

decide if a contract manufactur­er has the right facilities to

make your product for you. The third test, scheduled for the issue after next, deals with the selection - and se-

I lection pitfalls - of the most qualified contractor. Don't miss it.

Pharmaceutical fine chemicals:

MAKE OR BUY?